University of Iowa Participating in COVAIL Trial on Covid-19 Vaccine Boosters

University of Iowa Health Care is participating in a multi-center Phase 2 clinical trial evaluating various additional COVID-19 vaccine boosters. It’s the COVID-19 Variant Immunologic Landscape (COVAIL) trial, sponsored by the National Institute of Allery and Infectious Disease (NIAID). The trial “will test new and existing booster vaccines in various combinations to see which ones provide immune responses that cover existing and emerging COVID-19 variants.”

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About Me

I’m Jim Amos MD, the creator and author behind this blog. I’m a retired psychiatrist who enjoys playing cribbage, juggling and still loves life-long learning. Watch out; I’m gonna pull your leg! Check out my YouTube site

Contact Form below:

← Back

Thank you for your response. ✨